Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective
| Autor: | Merle L. Myerson, Dianna Gaballa, Rodis Paparodis, Robert A. Wild, Eugenia Gianos, Maya Balakrishnan, Dean G. Karalis, Eliot A. Brinton, Guy Mintz |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Endocrinology Diabetes and Metabolism 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Nonalcoholic fatty liver disease Internal Medicine medicine Humans 030212 general & internal medicine Obesity Intensive care medicine Pregnancy outcomes Life Style Cardiometabolic risk Nutrition and Dietetics Atherosclerotic cardiovascular disease business.industry Perspective (graphical) Cardiometabolic Risk Factors medicine.disease Menopause Cardiovascular Diseases Female Cardiology and Cardiovascular Medicine business Risk Reduction Behavior Biomarkers Lipidology |
| Zdroj: | Journal of clinical lipidology. 15(3) |
| ISSN: | 1933-2874 |
| Popis: | A recent rise in atherosclerotic cardiovascular disease (ASCVD) mortality in women warrants a heightened focus on the cardiometabolic risk factors that are closely tied to increasing trends in obesity and suboptimal lifestyle. Polycystic ovarian syndrome (PCOS), adverse pregnancy outcomes (APOs) and nonalcoholic fatty liver disease (NAFLD) are often manifestations of cardiometabolic disease that convey cardiovascular risk requiring recognition foremost, as well as a targeted approach to treatment. Similarly, menopause is a time to reflect on a woman's cardiovascular risk as multiple cardiometabolic changes occur during this time. Contraceptives and menopausal replacement therapy (MRT) should be considered along with a woman's individual thrombotic and cardiovascular risk. Clinicians should be attuned to cardiometabolic risk factors throughout a woman's lifespan and familiar with strategies to reduce cardiovascular risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect